U.S. News

FDA Says Merck's HIV Drug Gets Generic Threat

January 11, 2012

From CDC National Prevention Information Network
  • The Food and Drug Administration reports it has received applications from drugmakers who wish to produce generic versions of the HIV drugs Isentress (Merck & Co.) and Epivir (GlaxoSmithKline). Isentress was approved for use in adult patients in 2007; in December, FDA expanded its label, allowing the drug to be used in children and adolescents. FDA declined to disclose the names of the generic drug applicants.

    Back to other news for January 2012

Adapted from: Reuters
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: